Latest filing published 03 Aug 2015 for Sonnet BioTherapeutics Holdings, Inc., €6,586.
Insider track record
No signal scores available.
Paul I. Moskowitz: trading record in brief
Paul I. Moskowitz is a declared insider of Sonnet BioTherapeutics Holdings, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 30 March 2011 and the latest from 19 March 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 3 August 2015 came the latest disclosure, a share grant for €6,586 in Sonnet BioTherapeutics Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul I. Moskowitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,100 shares@ US$3.00Common StockSEC:0001493152-15-003335:0
- 5,000 shares@ US$2.69Common StockSEC:0001493152-15-003335:2
2 of 2 declarations